Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells.

MLA

Ning, Y., et al. “Endogenous and Synthetic Agonists of GPR119 Differ in Signalling Pathways and Their Effects on Insulin Secretion in MIN6c4 Insulinoma Cells.” British Journal of Pharmacology, vol. 155, no. 7, Dec. 2008, pp. 1056–65. EBSCOhost, https://doi.org/10.1038/bjp.2008.337.

APA

Ning, Y., O’Neill, K., Lan, H., Pang, L., Shan, L. X., Hawes, B. E., & Hedrick, J. A. (2008). Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells. British Journal of Pharmacology, 155(7), 1056–1065. https://doi.org/10.1038/bjp.2008.337

Chicago

Ning, Y, K O’Neill, H Lan, L Pang, L X Shan, B E Hawes, and J A Hedrick. 2008. “Endogenous and Synthetic Agonists of GPR119 Differ in Signalling Pathways and Their Effects on Insulin Secretion in MIN6c4 Insulinoma Cells.” British Journal of Pharmacology 155 (7): 1056–65. doi:10.1038/bjp.2008.337.